1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Huons Co., Ltd. - Product Pipeline Review - 2015

Huons Co., Ltd. - Product Pipeline Review - 2015

  • August 2015
  • -
  • Global Markets Direct
  • -
  • 29 pages

Huons Co., Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Huons Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Huons Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Huons Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Huons Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Huons Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Huons Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate Huons Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Huons Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Huons Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Huons Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Huons Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Huons Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Huons Co., Ltd. - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Huons Co., Ltd. Snapshot 5
Huons Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Huons Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Huons Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Huons Co., Ltd. - Pipeline Products Glance 12
Huons Co., Ltd. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Huons Co., Ltd. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Huons Co., Ltd. - Unknown Stage Pipeline Products 14
Unknown Products/Combination Treatment Modalities 14
Huons Co., Ltd. - Drug Profiles 15
HU-002 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
HU-010 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
HU-005 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
cyclosporine 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
HU-001 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
HU-003 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
HU-012 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
Huons Co., Ltd. - Pipeline Analysis 22
Huons Co., Ltd. - Pipeline Products by Target 22
Huons Co., Ltd. - Pipeline Products by Route of Administration 23
Huons Co., Ltd. - Pipeline Products by Molecule Type 24
Huons Co., Ltd. - Pipeline Products by Mechanism of Action 25
Huons Co., Ltd. - Company Statement 26
Huons Co., Ltd. - Locations And Subsidiaries 27
Head Office 27
Other Locations and Subsidiaries 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 28
Disclaimer 29

List of Tables
Huons Co., Ltd., Key Information 5
Huons Co., Ltd., Key Facts 5
Huons Co., Ltd. - Pipeline by Indication, 2015 7
Huons Co., Ltd. - Pipeline by Stage of Development, 2015 8
Huons Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Huons Co., Ltd. - Partnered Products in Pipeline, 2015 10
Huons Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015 11
Huons Co., Ltd. - Phase II, 2015 12
Huons Co., Ltd. - Preclinical, 2015 13
Huons Co., Ltd. - Unknown, 2015 14
Huons Co., Ltd. - Pipeline by Target, 2015 22
Huons Co., Ltd. - Pipeline by Route of Administration, 2015 23
Huons Co., Ltd. - Pipeline by Molecule Type, 2015 24
Huons Co., Ltd. - Pipeline Products by Mechanism of Action, 2015 25
Huons Co., Ltd., Other Locations 27

List of Figures
Huons Co., Ltd. - Pipeline by Top 10 Indication, 2015 7
Huons Co., Ltd. - Pipeline by Stage of Development, 2015 8
Huons Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Huons Co., Ltd. - Partnered Products in Pipeline, 2015 10
Huons Co., Ltd. - Pipeline by Top 10 Target, 2015 22
Huons Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015 23
Huons Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 24
Huons Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 7 (ITGA7) ...

Pulmonary Fibrosis - Pipeline Review, H2 2016

Pulmonary Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape. ...

Cognitive Impairment - Pipeline Review, H2 2016

Cognitive Impairment - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Cognitive Impairment - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape. ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.